CEO Robert Fremeau, PhD, to present at the Translational Models in Neuroscience Summit
October 24–26, 2023, Boston, MA.
CEO Robert Fremeau, PhD, presents at the Translatable Models in Neuroscience Summit, October 24–26, 2023, in Boston, MA.
Amongst the latest innovations in patient-derived iPSC models, 3D brain organoid models, advances in artificially driving neurodegeneration in vivo, and AI/ML methods to utilize messy biological data, biopharma is prioritizing preclinical models.
The Translatable Models in Neuroscience Summit is bringing together 50+ in vitro, in vivo, and in silico model developers transforming CNS disease recapitulation and bridging the translational gap.
This is an unrivaled opportunity to unite with neuroscientists, bioengineers, and AI/ML engineers to engage in meaningful discussion and advance CNS disease recapitulation, and catapult your pipeline toward the clinic.